Formative Usability Testing Study of a Novel Medical Device for Peritoneal Dialysis (WEAKID)
NCT ID: NCT07131995
Last Updated: 2025-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2021-11-01
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
First-in-human Study to Examine Safety of a New Peritoneal Dialysis Device (WEAKID) in End-stage Kidney Disease Patients
NCT06314503
Intra-abdominal Pressure in Peritoneal Dialysis Patients
NCT02811640
Efficacy and Tolerability of the APD Treatment in PAED Patients
NCT07004907
Improving Outcomes in Peritoneal Dialysis
NCT02207751
Peritoneal Dialysis Versus Haemodialysis
NCT00752583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nurses
Nurses, aged 18 years or older, and having \>1 years of professional experience with PD.
No interventions assigned to this group
Patients
Patients, aged 18 years or older, having a clinical diagnosis of ESRD and any treatment experience with PD, either current or in the past.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients: aged 18 years or older, clinical diagnosis of ESRD, any treatment experience with PD, either current or in the past.
Exclusion Criteria
* Patients: severe physical and/or cognitive impairment, as judged by the researchers.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario La Paz
OTHER
Azienda Unita' Sanitaria Locale Di Modena
OTHER
UMC Utrecht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karin G.F. Gerritsen
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21/616
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.